Clinical Trial Update: A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer [Phase 1]

View source ↗

Summary

This update reports that ThermalCore Inc.'s Phase 1 trial of Perfusion Induced Systemic Hyperthermia for terminal ovarian cancer is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: ThermalCore Inc | Conditions: Ovarian Cancer | Phase 1 | Status: SUSPENDED